Oncolytics ready for final step with Reolysin
May 18, 2010 by leonardzehr · Leave a Comment
After a 10-year journey, Oncolytics Biotech (TSX:ONC; NASDAQ:ONCY ) is ready to take the final clinical step with its sole Reolysin drug as a treatment for a broad range of cancers. “Our product has really shown a breadth of activity in a wide variety of cancers that we had hoped it would way back when [...]
Listen to BioTuesdays 
